Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Soluble IL-7Ralpha (sCD127) and measurement of IL-7 in the plasma of HIV patients.

Blom-Potar MC, Bugault F, Lambotte O, Delfraissy JF, Thèze J.

J Acquir Immune Defic Syndr. 2009 May 1;51(1):104-5. doi: 10.1097/QAI.0b013e31819d8a20. No abstract available.

PMID:
19390329
2.

Persistent human immunodeficiency virus-1 antigenaemia affects the expression of interleukin-7Ralpha on central and effector memory CD4+ and CD8+ T cell subsets.

Mercier F, Boulassel MR, Yassine-Diab B, Tremblay C, Bernard NF, Sekaly RP, Routy JP.

Clin Exp Immunol. 2008 Apr;152(1):72-80. doi: 10.1111/j.1365-2249.2008.03610.x. Epub 2008 Feb 14.

3.

Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation.

Rajasuriar R, Booth D, Solomon A, Chua K, Spelman T, Gouillou M, Schlub TE, Davenport M, Crowe S, Elliott J, Hoy J, Fairley C, Stewart G, Cameron P, Lewin SR.

J Infect Dis. 2010 Oct 15;202(8):1254-64. doi: 10.1086/656369.

4.

Identification and biochemical characterization of human plasma soluble IL-7R: lower concentrations in HIV-1-infected patients.

Rose T, Lambotte O, Pallier C, Delfraissy JF, Colle JH.

J Immunol. 2009 Jun 15;182(12):7389-97. doi: 10.4049/jimmunol.0900190.

5.

The correlation between levels of IL-7Ralpha expression and responsiveness to IL-7 is lost in CD4 lymphocytes from HIV-infected patients.

Colle JH, Moreau JL, Fontanet A, Lambotte O, Delfraissy JF, Thèze J.

AIDS. 2007 Jan 2;21(1):101-3.

PMID:
17148974
6.

A validated assay to measure soluble IL-7 receptor shows minimal impact of IL-7 treatment.

Janot-Sardet C, Assouline B, Cheynier R, Morre M, Beq S.

J Immunol Methods. 2010 Feb 28;353(1-2):115-23. doi: 10.1016/j.jim.2009.12.003. Epub 2009 Dec 24.

PMID:
20035760
7.
8.

Disruption of the gamma c cytokine network in T cells during HIV infection.

Sirskyj D, Thèze J, Kumar A, Kryworuchko M.

Cytokine. 2008 Jul;43(1):1-14. doi: 10.1016/j.cyto.2008.03.001. Epub 2008 Apr 15. Review.

PMID:
18417356
9.

Soluble IL-7R alpha (sCD127) inhibits IL-7 activity and is increased in HIV infection.

Crawley AM, Faucher S, Angel JB.

J Immunol. 2010 May 1;184(9):4679-87. doi: 10.4049/jimmunol.0903758. Epub 2010 Mar 19.

10.

Progressive CD127 down-regulation correlates with increased apoptosis of CD8 T cells during chronic HIV-1 infection.

Zhang SY, Zhang Z, Fu JL, Kang FB, Xu XS, Nie WM, Zhou CB, Zhao M, Wang FS.

Eur J Immunol. 2009 May;39(5):1425-34. doi: 10.1002/eji.200839059.

11.

Loss of CD127 expression links immune activation and CD4(+) T cell loss in HIV infection.

Kiazyk SA, Fowke KR.

Trends Microbiol. 2008 Dec;16(12):567-73. doi: 10.1016/j.tim.2008.08.011. Epub 2008 Oct 27.

PMID:
18964017
12.

Decreased systemic IL-7 and soluble IL-7Rα in multiple sclerosis patients.

Kreft KL, Verbraak E, Wierenga-Wolf AF, van Meurs M, Oostra BA, Laman JD, Hintzen RQ.

Genes Immun. 2012 Oct;13(7):587-92. doi: 10.1038/gene.2012.34. Epub 2012 Aug 23.

PMID:
22914435
13.

Application of flow cytometric beads for simultaneous CD4 and CD8 determinations in HIV-1 infected thalassemia patients.

Tiensiwakul P, Boonmongkol P, Nonsee N, Bunchontevakul S, Desudchit P.

J Med Assoc Thai. 2009 Mar;92(3):398-404.

PMID:
19301735
14.

Development of a quantitative bead capture assay for soluble IL-7 receptor alpha in human plasma.

Faucher S, Crawley AM, Decker W, Sherring A, Bogdanovic D, Ding T, Bergeron M, Angel JB, Sandstrom P.

PLoS One. 2009 Aug 19;4(8):e6690. doi: 10.1371/journal.pone.0006690.

15.

Antiretroviral therapy initiation during primary HIV infection enhances both CD127 expression and the proliferative capacity of HIV-specific CD8+ T cells.

Lécuroux C, Girault I, Boutboul F, Urrutia A, Goujard C, Meyer L, Lambotte O, Chaix ML, Martinez V, Autran B, Sinet M, Venet A; ANRS PRIMO Cohort, ANRS HIC Study Group; ANRS ALT Cohort; ANRS HIC Study Group.

AIDS. 2009 Aug 24;23(13):1649-58. doi: 10.1097/QAD.0b013e32832e6634.

PMID:
19617814
16.

Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin-7-induced immune activation in rheumatoid arthritis.

Hartgring SA, van Roon JA, Wenting-van Wijk M, Jacobs KM, Jahangier ZN, Willis CR, Bijlsma JW, Lafeber FP.

Arthritis Rheum. 2009 Sep;60(9):2595-605. doi: 10.1002/art.24754.

17.

[CD4 lymphocytes as targets and actors in the pathogenesis of HIV infection--therapeutic implications].

Theze J.

Bull Acad Natl Med. 2008 Oct;192(7):1453-66; discussion 1466-8. Review. French.

PMID:
19445368
18.

Interleukin 7 receptor alpha as a potential therapeutic target in transplantation.

Racapé M, Vanhove B, Soulillou JP, Brouard S.

Arch Immunol Ther Exp (Warsz). 2009 Jul-Aug;57(4):253-61. doi: 10.1007/s00005-009-0036-7. Epub 2009 Jul 8. Review.

PMID:
19585222
19.

Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia.

Santner-Nanan B, Peek MJ, Khanam R, Richarts L, Zhu E, Fazekas de St Groth B, Nanan R.

J Immunol. 2009 Dec 1;183(11):7023-30. doi: 10.4049/jimmunol.0901154. Epub 2009 Nov 13.

20.

Could natural killer cells compensate for impaired CD4+ T-cell responses to CMV in HIV patients responding to antiretroviral therapy?

Tan DB, Fernandez S, French M, Price P.

Clin Immunol. 2009 Jul;132(1):63-70. doi: 10.1016/j.clim.2009.03.518. Epub 2009 Apr 28.

PMID:
19403337
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk